secwatch.observer — SEC 8-K summary
======================================

Issuer:     TuHURA Biosciences, Inc./NV (HURA)
CIK:        0001498382
Form:       8-K
Filed at:   2025-11-04T23:59:59+00:00
Accession:  0001193125-25-263523
Event type: other_material
Sentiment:  neutral
Materiality: 0.50
Item codes: 1.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

TuHURA Biosciences enters ATM agreement for up to $50M in common stock sales
----------------------------------------------------------------------------

- Up to $50M of common stock may be sold through H.C. Wainwright as sales agent.
- Wainwright receives 3.0% cash commission; company reimburses up to $75K in legal fees.
- Proceeds will be used for working capital and general corporate purposes.
- Either party may suspend or terminate the offering; no assurance any shares will be sold.
- Registration statement on Form S-3 filed same day; sales begin once SEC declares effective.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1498382/000119312525263523/0001193125-25-263523-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1498382/000119312525263523/hura-20251103.htm
  HTML page:      https://secwatch.observer/filing/0001193125-25-263523

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer